The flu vaccine is just 17% effective against the current virus; Indiana dropped 25,000 people from its Medicaid program for not paying premiums; the CDC is cutting back on efforts to prevent infectious disease outbreaks in other countries as funding runs out.
The current flu season has been particularly harsh, with 41.9 hospitalizations per 100,000 people and approximately 40 pediatric deaths. New research in Canada has found that the vaccine has just been 17% effective at preventing infection, reported STAT. Last year, the vaccine was estimated to be 37% effective in Canada. The CDC has yet to analyze its midseason flu vaccine effectiveness data and expects to publish its analysis in a few weeks. The findings confirm that people who have been vaccinated are still contracting the flu.
In Indiana, the Medicaid program was expanded under the Affordable Care Act with some changes approved by the Obama administration, namely monthly fees and lockout provisions. According to Kaiser Health News, those provisions led to 25,000 adults being disenrolled from Medicaid between 2015 and October 2017. Half of those dropped from the program had found another source of coverage, mostly through a job. Another 46,000 adults were not accepted into the program during 2016 and 2017 because they did not pay their initial premiums.
With money running out, the United States is going to scale back its involvement in preventing infectious disease epidemics in 39 of 49 countries. The Washington Post reported that the CDC had been given $600 million by Congress in 2014 to help countries combat infectious disease outbreaks, but the money will run out in September 2019. The agency has been notifying officials abroad about plans to downsize its epidemic prevention activities under the assumption that the Trump administration will not budget additional resources.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More